Want to create an interactive transcript for this episode?
Podcast: Surfing the MASH Tsunami
Episode: S4-E8.1 - Utilizing Prescription Digital Therapeutics to Combat Fatty Liver
Description: For the first time, Surfing NASH takes a deep dive into the prospect of digital therapeutics, their ability to drive outcomes and the critical success factors for proper use and deployment. This is an increasingly apt topic which intermittently surfaces on the podcast but has never featured at the center of conversation. The Surfers are joined by Naim Alkhouri and two new guests with prominent focus in this space: Joe Rubinsztain, CEO and Co-Founder of ChronWell, and Mark Berman, CMO of Better Therapeutics.In this conversation, Joe and Mark detail their backgrounds and respective roles at two...